|
Name |
N-(Carboxymethyl)anthranilic acid
|
Molecular Formula | C9H9NO4 | |
IUPAC Name* |
2-(carboxymethylamino)benzoic acid
|
|
SMILES |
C1=CC=C(C(=C1)C(=O)O)NCC(=O)O
|
|
InChI |
InChI=1S/C9H9NO4/c11-8(12)5-10-7-4-2-1-3-6(7)9(13)14/h1-4,10H,5H2,(H,11,12)(H,13,14)
|
|
InChIKey |
PJUXPMVQAZLJEX-UHFFFAOYSA-N
|
|
Synonyms |
612-42-0; N-(2-Carboxyphenyl)glycine; N-(Carboxymethyl)anthranilic acid; 2-[(carboxymethyl)amino]benzoic acid; 2-((Carboxymethyl)amino)benzoic acid; 2-(carboxymethylamino)benzoic acid; Benzoic acid, 2-[(carboxymethyl)amino]-; Phenylglycine-o-carboxylic acid; 2-(Carboxymethyl-amino)-benzoic acid; Glycine, N-(o-carboxyphenyl)-; Anthranilic acid, N-(carboxymethyl)-; MFCD00020445; Benzoic acid, 2-((carboxymethyl)amino)-; 141865-09-0; 2-[(Carboxymethyl)Amino]-Benzoicaci; N-Phenylglycine-o-carboxylic acid; EINECS 210-311-5; NSC 80600; o-carboxyphenylglycine; Anthranilinoacetic acid; Cambridge id 5108438; Oprea1_043997; Oprea1_087556; CBDivE_014055; MLS000680124; BIDD:GT0666; SCHEMBL341645; CHEMBL443231; IFLab1_000341; DTXSID9060609; ZINC50907; HMS1412P11; HMS2745I07; NSC80600; BBL023541; NSC-80600; STK698970; AKOS000274214; CS-W010629; HY-W009913; IDI1_008560; NCGC00246622-01; AC-17985; BP-12709; SMR000324392; DB-080992; FT-0629270; (Carbomethoxymethyl)triphenylphosphoniumbromide; D78226; AH-034/04643009; Q27454068; 3RG
|
|
CAS | 612-42-0 | |
PubChem CID | 69161 | |
ChEMBL ID | CHEMBL443231 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 195.17 | ALogp: | 1.7 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 86.6 | Aromatic Rings: | 1 |
Heavy Atoms: | 14 | QED Weighted: | 0.674 |
Caco-2 Permeability: | -5.98 | MDCK Permeability: | 0.00001000 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.086 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.626 |
Blood-Brain-Barrier Penetration (BBB): | 0.22 | Plasma Protein Binding (PPB): | 61.49% |
Volume Distribution (VD): | 0.197 | Fu: | 31.37% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.037 |
CYP2C19-inhibitor: | 0.079 | CYP2C19-substrate: | 0.043 |
CYP2C9-inhibitor: | 0.163 | CYP2C9-substrate: | 0.257 |
CYP2D6-inhibitor: | 0.029 | CYP2D6-substrate: | 0.121 |
CYP3A4-inhibitor: | 0.027 | CYP3A4-substrate: | 0.015 |
Clearance (CL): | 2.127 | Half-life (T1/2): | 0.857 |
hERG Blockers: | 0.057 | Human Hepatotoxicity (H-HT): | 0.281 |
Drug-inuced Liver Injury (DILI): | 0.706 | AMES Toxicity: | 0.017 |
Rat Oral Acute Toxicity: | 0.02 | Maximum Recommended Daily Dose: | 0.005 |
Skin Sensitization: | 0.491 | Carcinogencity: | 0.016 |
Eye Corrosion: | 0.027 | Eye Irritation: | 0.946 |
Respiratory Toxicity: | 0.619 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000055 | 0.591 | D07HBX | 0.512 | ||||
ENC003916 | 0.509 | D0GY5Z | 0.490 | ||||
ENC000073 | 0.490 | D0N3UL | 0.442 | ||||
ENC005325 | 0.483 | D0G2MH | 0.426 | ||||
ENC000301 | 0.439 | D05FTJ | 0.397 | ||||
ENC001443 | 0.429 | D08IFL | 0.385 | ||||
ENC000409 | 0.417 | D0F5ZM | 0.379 | ||||
ENC001333 | 0.388 | D0Y0JH | 0.379 | ||||
ENC005757 | 0.385 | D0B2WJ | 0.368 | ||||
ENC000108 | 0.383 | D0E6OC | 0.364 |